Clinical Trials List
2018-10-01 - 2021-03-31
Phase I
Recruiting3
Terminated1
-
Trial Applicant
Linical
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳國興 Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
- Chen-Yuan Lin Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Su-Peng Yeh Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Nai-Jung Chiang Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- Kwang-Yu Chang Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- Yan-Shen Shan Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- Kwang-Yu Chang Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- Yan-Shen Shan Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
60 participants